ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
Premium Icon프리미엄 Help Menu
S&P 500
5,982.72
-0.84%
US Tech 100
21,112.40
-1.21%
다우존스 지수
42,215.80
-0.70%
Bitcoin
105,494.41
0.86%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. Capricor Therapeutics Inc (CAPR) 시세

Capricor Therapeutics Inc

Capricor Therapeutics Inc (CAPR)

Caprock Mining Corp
12.19
-0.19
(-1.53%)
마감 18 6월 5:00AM
15분 지연 - 실시간으로 업그레이드
12.23
0.04
(0.33%)
시간외 거래: 8:59AM
15분 지연 - 실시간으로 업그레이드

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

프리미엄

주요 통계 및 세부정보

가격
12.23
매수가
12.03
매도가
12.19
거래량
2,559,013
11.57 일간 변동폭 13.51
3.52 52주 범위 23.40
market_cap
559.007M
전일 종가
12.38
개장가
12.12
최근 거래 시간
1
@
12.11
마지막 거래 시간
재정 규모
US$ 32,142,772
VWAP
12.5606
평균 볼륨(3m)
2,263,790
발행 주식
45,707,819
배당수익률
-
주가수익률
-13.76
주당순이익(EPS)
-0.89
매출
22.27M
순이익
-40.47M

Capricor Therapeutics Inc 정보

Capricor Therapeutics, Inc. is a San Diego based biotechnology company focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of muscular and other select diseases. Capricor's lead candidate, CAP-1002, is an allogeneic cardiac-derived cell t... Capricor Therapeutics, Inc. is a San Diego based biotechnology company focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of muscular and other select diseases. Capricor's lead candidate, CAP-1002, is an allogeneic cardiac-derived cell therapy that is currently in late-stage clinical development for treating Duchenne muscular dystrophy (DMD). Capricor is also developing its exosome technology as a next-generation therapeutic platform. Capricor's proprietary StealthX¿ exosome platform has potential for a broad range of new therapeutic applications in the field of vaccinology as well as targeted oligonucleotide, protein and small molecule therapeutics to treat or prevent a variety of diseases. 더 보기

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
www.capricor.com
본부
Wilmington, Delaware, USA
설립됨
-
Capricor Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker CAPR. The last closing price for Capricor Therapeutics was US$12.38. Over the last year, Capricor Therapeutics shares have traded in a share price range of US$ 3.52 to US$ 23.40.

Capricor Therapeutics currently has 45,707,819 shares in issue. The market capitalisation of Capricor Therapeutics is US$565.86 million. Capricor Therapeutics has a price to earnings ratio (PE ratio) of -13.76.

Capricor Therapeutics (CAPR) 옵션 플로우 요약

전체 옵션 플로우 보기

전체 흐름

강세

순 프리미엄

835k

Calls / Puts

666.67%

매수 / 매도

91.67%

OTM / ITM

666.67%

Sweeps 비율

0.00%

CAPR 최신 뉴스

추가 뉴스

Form S-8 - Securities to be offered to employees in employee benefit plans
Edgar (US Regulatory)
17 6월 2025
CAPR (-1.53%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
15 5월 2025
CAPR (-1.53%)

Form 8-K - Current report
Edgar (US Regulatory)
14 5월 2025
CAPR (-1.53%)

Form ARS - Annual Report to Security Holders
Edgar (US Regulatory)
10 4월 2025
CAPR (-1.53%)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-1.07-8.0451127819513.314.2611.75005223422112.76682408CS
41.3712.615101289110.86159.53210585111.89700624CS
12-0.97-7.3484848484813.2156.2722637909.90538317CS
26-1.57-11.376811594213.816.4656.27171428211.34827926CS
527.07137.0155038765.1623.43.52182722012.67432594CS
1568.18201.9753086424.0523.42.6873679111.31924477CS
2607.53160.2127659574.723.42.567508859.05955921CS

CAPR - Frequently Asked Questions (FAQ)

What is the current Capricor Therapeutics share price?
The current share price of Capricor Therapeutics is US$ 12.23
How many Capricor Therapeutics shares are in issue?
Capricor Therapeutics has 45,707,819 shares in issue
What is the market cap of Capricor Therapeutics?
The market capitalisation of Capricor Therapeutics is USD 565.86M
What is the 1 year trading range for Capricor Therapeutics share price?
Capricor Therapeutics has traded in the range of US$ 3.52 to US$ 23.40 during the past year
What is the PE ratio of Capricor Therapeutics?
The price to earnings ratio of Capricor Therapeutics is -13.76
What is the cash to sales ratio of Capricor Therapeutics?
The cash to sales ratio of Capricor Therapeutics is 25
What is the reporting currency for Capricor Therapeutics?
Capricor Therapeutics reports financial results in USD
What is the latest annual turnover for Capricor Therapeutics?
The latest annual turnover of Capricor Therapeutics is USD 22.27M
What is the latest annual profit for Capricor Therapeutics?
The latest annual profit of Capricor Therapeutics is USD -40.47M
What is the registered address of Capricor Therapeutics?
The registered address for Capricor Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Capricor Therapeutics website address?
The website address for Capricor Therapeutics is www.capricor.com
Which industry sector does Capricor Therapeutics operate in?
Capricor Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
CEROCERo Therapeutics Holdings Inc
US$ 19.92
(190.04%)
57.35M
ACXPAcurx Pharmaceuticals Inc
US$ 0.8149
(165.35%)
337.45M
EYENEyenovia Inc
US$ 6.96
(134.34%)
29.94M
RBNERobin Energy Ltd
US$ 10.60
(92.03%)
45.44M
RELIReliance Global Group Inc
US$ 2.20
(86.44%)
19.29M
SDSTStardust Power Inc
US$ 0.186
(-52.10%)
39.42M
SHOTWSafety Shot Inc
US$ 0.0161
(-45.97%)
12.35k
RUNSunrun Inc
US$ 5.78
(-40.04%)
120.05M
SEDGSolarEdge Technologies Inc
US$ 15.94
(-33.53%)
33.14M
GOVXGeoVax Labs Inc
US$ 0.8924
(-32.39%)
2.64M
PCSAProcessa Pharmaceuticals Inc
US$ 0.2632
(16.93%)
575.5M
GNLNGreenlane Holdings Inc
US$ 0.0104
(-16.13%)
392.94M
HCTIHealthcare Triangle Inc
US$ 0.022
(-16.67%)
356.57M
ACXPAcurx Pharmaceuticals Inc
US$ 0.8149
(165.35%)
337.45M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 11.9373
(-7.75%)
143.55M

CAPR Discussion

게시물 보기
D-bol D-bol 2 주 전
I've been holding since 2021. What does everybody expect this to be this year?
👍️0
D-bol D-bol 2 주 전
Are you still here?
👍️0
GreedyAgorist GreedyAgorist 1 월 전
Anyone want to explain this complete pump eradication? It lasted 8 months... so... congrats on that, bulls.

So far it has been profitable to sell cash covered puts on this one when it has big drops, so I guess I should be happy for the opportunity, but I must say I did not expect to be looking at the 5's again. Only six weeks ago, I was selling a 25 call.
👍️0
koolmc koolmc 1 월 전
on watch again for another trade over reaction should see 10's again
👍️0
koolmc koolmc 2 월 전
trying for 14's now :)
👍️0
koolmc koolmc 2 월 전
13s :)
👍 1
koolmc koolmc 2 월 전
:)
👍️0
koolmc koolmc 2 월 전
if it breaks 12 and hold then uptrend confirms, although market not helping would be up more, but someone got a heads up here :)
👍️0
koolmc koolmc 2 월 전
yep finally sold some today after averaging down, will hold some into the forward event gl.
👍️0
ed3/6me ed3/6me 2 월 전
Life!
👍️0
ed3/6me ed3/6me 3 월 전
Bought back at 12.80 from 14.40. 
👍️0
koolmc koolmc 3 월 전
added 12 on dip, also got shares for short term trading gl
👍️0
koolmc koolmc 3 월 전
there it is below 12's again
👍️0
koolmc koolmc 3 월 전
up in down market today.
👍️0
koolmc koolmc 3 월 전
up in down market today.
👍️0
ed3/6me ed3/6me 3 월 전
Mid 12 is target again
👍️0
koolmc koolmc 3 월 전
Yep got plenty of time to accumulate cheapies before expected approval date wouldn't mind below 12s again to add.
👍️0
ed3/6me ed3/6me 3 월 전
waITING ON SIDELINES. AS THEY ARE NOT AGRESSIVE ENOUGH TO PUSH BUYING PRESSURE AS OF YET. THEY NEED SOMETHING TO STIMULATE THE NEED TO BE AGRESSIVE HERE.
👍️0
koolmc koolmc 3 월 전
yep same here will add to starter position i got last week for push into august then sell on news
👍️0
ed3/6me ed3/6me 3 월 전
Sold at 14.40 waiting now
👍️0
enthalpy enthalpy 3 월 전
It was strictly options and a great ER. Did you listen to it? I am going to load the boat in late April or early May probably another 20k. Wishing you and your family well. Enthalpy.
👍️0
enthalpy enthalpy 3 월 전
Hey Ed. Q4 2024 was a good time was is it not on CAPR. This is company is going to make it i think. ESpecially now that SRPT killed a kid. CAPR might become number 1 in DMD if they can get their drug approved. I sold a chunk at $18. Bought back at 11.80. Hope your doing man.
👍️0
ed3/6me ed3/6me 3 월 전
ANY RATIONAL TO THE BUMP YESTERDAY? THOUGHT THE TREND WAS SLIGHTLY LOWER TILL NEXT QUARTER AS THE COMPANY STILL HAS NO REAL APPROVAL YET
👍️0
ed3/6me ed3/6me 3 월 전
Agree about timing this. Lately it's a crapshoot anywhere. Market is unstable at best while war and tariffs/inflation are on front burner. Judges blocking the inevitable re evaluation of scope of government outreach clouds the pictures market cannot get a clear sense of direction. Think we still have 2-3 months of bounce here in investment land
👍️0
GreedyAgorist GreedyAgorist 3 월 전
So the bumpy ride is thanks to delaying the earnings report twice? (Or maybe the brokers were giving me bad info just to make me look foolish for the last two weeks.)

: - )

Now I wonder... does clearing this hurdle mean the monthly bottom was yesterday? Two days left for options expiration.
I will be picking up more shares at the end of the week. Just not sure how many. Price below or above 12.50 will determine that.
👍️0
ed3/6me ed3/6me 3 월 전
Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, will release its financial results for the fourth quarter and full year ended December 31, 2024, after the market close on Wednesday, March 19, 2025. Management will then host a webcast and conference call at 4:30 p.m. ET on March 19.
👍️0
ed3/6me ed3/6me 3 월 전
Nbd
👍️0
GreedyAgorist GreedyAgorist 3 월 전
Sorry, I could have sworn earnings were Wednesday last week, but they are this coming week, 3/12 after hours. Did one or two brokers lead me astray? Or was I looking at Rigetti or some other speculative play on my watchlist and got confused? Anyway…

Last week we did get some corporate stuff, some Form 4’s and an 8K, but no earnings yet. I thought the wild swings were in response to a quarterly report, and the worst of it was over, but no such luck.

Well, if it drops to 12, I will sell a 10 for April. Good luck to all.

And condolences to anyone who loses somebody over this stupid DST nonsense. When exactly does the making ourselves healthy again start? Certainly not this weekend.
👍️0
ed3/6me ed3/6me 3 월 전
can live with price short term. and hope they finally get going toward some kind of goal
👍 1
ed3/6me ed3/6me 3 월 전
Thanks. Will pay better attention next time 
👍️0
GreedyAgorist GreedyAgorist 3 월 전
You realize that earnings is today after hours. No doubt they will post a loss, as we are not at the point of having positive revenue yet, but just need to not disappoint.

Well, at least if you bought today, that is better than the recent top when it was 30% more expensive.

Still two and a half weeks until March contracts expire. A risk taker would position today, not wait until tomorrow, after the report. How brave am I feeling?
👍️0
ed3/6me ed3/6me 3 월 전
Jumped back in. Hope it helps me
👍️0
GreedyAgorist GreedyAgorist 4 월 전
Wow, I hardly ever perfectly time the bottom, but I sold a cash covered put today when it was red, and before I could second guess my play, it was green and up more than two bucks.

Any explanation for the 12% gain?

Oh, well, we were here ten days ago. Nothing to get excited about, right?
👍️0
Mr.Mister Mr.Mister 5 월 전
With BLA submission in late December, when would the FDA have to accept or reject their application by? Late February?
👍️0
Volcano Volcano 5 월 전
Breaking out now
Get ready for $70 upon FDA approval
💯 1 🔥 1
Volcano Volcano 5 월 전
Price target $70-$100 upon FDA approval in a few months
Multi millionaire soon to be
👍 1
XWAVXALMIMAN XWAVXALMIMAN 5 월 전
We got the news. We finished the submission and got $10 million. People are so impatient. I’ve waited 4 1/2 years. I can wait 6-9 months for approval. Families and patients should be pushing for a much quicker approval. 30-40 in 2025.
👍️0
D-bol D-bol 6 월 전
Maybe news tomorrow
👍️0
MomsSpaghetti MomsSpaghetti 6 월 전
My question to you CAPR folks who are likely more versed than I. Is after the submission is sent to FDA for approval (in your case Deramiocel (CAP-1002)) - How long does it take FDA to make a decision on average?

I am following another company MNMD that is in Phase 3 right now for LSD that got FDA Break Through Designation.
👍️0
GreedyAgorist GreedyAgorist 6 월 전
Guess I was wrong about the new 5. It is not 20 or 17.50. Not yet. Those were the pump prices. If the pump is over for now, we might hang out around 12.50 for a while, making puts at 12.50 and 10 interesting. Likewise calls at 15 might be worth a shot. Although my next play is targeting March 17.50. If it gets there early, that will inform my next move.
👍️0
XWAVXALMIMAN XWAVXALMIMAN 6 월 전
You’ll be sorry. Definitely an easy double from here within a year. I’ve held most shares for 4 1/2 years. Be patient. Linda sounded great - listened to interview last night after 12 days in Puerto Vallarta
👍️ 1
Laster Laster 6 월 전
Got out yesterday afternoon before that huge dump.
It looked like it wanted to drop below $16.
Crazy AH trading down to $11 and back to $16.
Concern about one of their investigators.
Either way, I am out and hope others can make a better trade than I did. Now moving my money to other more quality stocks. JMO.
👍️0
D-bol D-bol 6 월 전
What a day. Still not selling.
👍️0
PonkenPlonken PonkenPlonken 6 월 전
RFK is irrelevant to how CAPR moves.

Everything is in the price here... plus a lot of birds in the bush. Why anyone would hold this stock AFTER it all happened, no catalyst on the horizeon. Presentation roadmap ends at "today".... is clear indication they know nothing will happen for a good year or two. So it will need a breather - which I believe you see in the chart.

Bios run towards events - not because of them.
GL
👍️0
Laster Laster 6 월 전
Thank you. I have patience and can wait for mid 2025.
The problem is the biotech sector. It has gotten destroyed since Trump picked RFK Jr. as HHS secretary. Hopefully it will recover if RFK Jr. somehow doesn’t get the job.
Just hate the BS manipulation to drop stocks on no news. The stock market is a joke. Many Stocks now move on no news. I have seen stocks move from $1 to $10 on nothing. How is that possible or legal?
Just hope it doesn’t drop lower than $15. Then I might have to throw in the towel and move on.
👍️0
PonkenPlonken PonkenPlonken 6 월 전
This stock trades on a lot of hopes, dreams and "ifs".
Not unlikely that whatever they announce, it will be a sell on news event.
It believe it has to cool off until the PDUFA which is ca 1 year away.
When the roadmap a company gives in their presentation ends with "today"...... is usually not a good sign. That is speaking in terms of PPS. For the company, everything is well and funding wont be an issue.
👍️0
Laster Laster 6 월 전
Now down to $17.50. WOW. I can only guess people were expecting news on the BLA submission.
Maybe they are getting financing through the ATM and selling into the market.
Either way, this doesn't look good today.
👍️0
Laster Laster 6 월 전
This stock is ridiculous. I don't know if it is manipulation or MMs getting the stop losses?
Opened at $19.44 and then in 1 minute it went to $20.75 and then the next minute it is down to $18.92.
Clearly, someone continues to keep this below $20. When will they be done????
This is criminal IMO. I am holding because I think it makes a run to $30 once all this crap is over.
MACD histogram on the daily is going to turn positive today.
JMO.
👍️0
Laster Laster 6 월 전
The stock chart looks interesting. The MACD histogram is ready to turn positive.
The stock found support at the 25 day moving average.
PnF chart clearly shows double/triple top breakout past $21.
Nice flag forming. Needs volume to move past $20.
I think the stock will need BLA news to get the volume to move past $20.
I am looking for $30-$40 by mid 2025.

FYI. Conferences this week and next week.
Perfect time to release some updates.
👍 1
Laster Laster 7 월 전
Well yesterday sucked. Moved BACK to $20 again only to get dumped back down to $19.
Looks like it will need significant volume to move back above $20.
2 conferences in early to mid December might help.
Happy Thanksgiving.
👍️0

최근 히스토리

NASDAQ
CAPR
Capricor Therapeutics
Delayed Upgrade Clock
ADVFN Logo
대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN Ltd - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지